NeuBase Therapeutics, Inc. Annual Depreciation in USD from 2010 to 2021

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2010 to 2021.
  • NeuBase Therapeutics, Inc. Depreciation for the quarter ending September 30, 2023 was $100K, a 50% decline year-over-year.
  • NeuBase Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2023 was $700K, a 12.5% decline year-over-year.
  • NeuBase Therapeutics, Inc. annual Depreciation for 2021 was $400K, a 300% increase from 2020.
  • NeuBase Therapeutics, Inc. annual Depreciation for 2020 was $100K, a 400% increase from 2019.
  • NeuBase Therapeutics, Inc. annual Depreciation for 2019 was $20K, a 95.7% increase from 2018.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $400K +$300K +300% Oct 1, 2020 Sep 30, 2021 10-K 2021-12-23
2020 $100K +$80K +400% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
2019 $20K +$9.78K +95.7% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-23
2018 $10.2K -$34.9K -77.3% Oct 1, 2017 Sep 30, 2018 10-K 2019-01-03
2017 $45.1K -$19.6K -30.3% Oct 1, 2016 Sep 30, 2017 10-K 2019-01-03
2016 $64.6K +$24K +59.1% Oct 1, 2015 Sep 30, 2016 10-K 2017-12-15
2015 $40.6K +$22.8K +128% Oct 1, 2014 Sep 30, 2015 10-K 2016-12-22
2014 $17.9K +$4.49K +33.6% Oct 1, 2013 Sep 30, 2014 10-K 2016-12-22
2013 $13.4K +$3.9K +41.2% Oct 1, 2012 Sep 30, 2013 10-K 2015-12-14
2012 $9.46K +$4.45K +89% Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
2011 $5K +$4.15K +489% Oct 1, 2010 Sep 30, 2011 10-K 2013-01-09
2010 $850 Oct 1, 2009 Sep 30, 2010 10-K/A 2012-01-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.